Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Melanoma, Secondary cancers, Skin cancer
Closed
Phase 2
This study is looking at adding IMM-101 to nivolumab for melanoma that has grown into surrounding tissues or spread elsewhere in the body. This is called advanced melanoma.
Recruitment start: 4 October 2018
Recruitment end: 1 June 2020
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Alberto Fusi
Immodulon Therapeutics Limited
Last reviewed: 29 June 2021
CRUK internal database number: 15720
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
